TrialThe Lancet. Respiratory medicine2019

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.

John H Beigel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.